Transmembrane protein 97 is a potential synaptic amyloid beta receptor in human Alzheimer's diseaseACTA NEUROPATHOLOGICAIF9.32024-02-066OAAI
A phase 1b randomized clinical trial of CT1812 to measure Aβ oligomer displacement in Alzheimer's disease using an indwelling CSF catheterTRANSLATIONAL NEURODEGENERATIONIF15.22023-05-1213OAAI
Screening of?2Receptor Ligands and In Vivo Evaluation of 11C-Labeled 6,7-Dimethoxy-2-[4-(4-methoxyphenyl)butan-2-yl]-1,2,3,4-tetrahydroisoquinoline for Potential Use as a ?2ReceptorBrain PET TracerJOURNAL OF MEDICINAL CHEMISTRYIF6.82022-04-1113PRE
Discovery of Investigational Drug CT1812, an Antagonist of the Sigma-2 Receptor Complex for Alzheimer's DiseaseACS MEDICINAL CHEMISTRY LETTERSIF42021-08-0933OAAI
Preclinical and clinical biomarker studies of CT1812: A novel approach to Alzheimer's disease modificationALZHEIMERS & DEMENTIAIF11.12021-02-0857OA
The clinical promise of biomarkers of synapse damage or loss in Alzheimer's disease阿尔茨海默氏病突触损伤或丧失的生物标志物的临床前景ALZHEIMERS RESEARCH & THERAPYIF7.62020-03-02213OAAI
Clinical diagnosis of potentially treatable early articular cartilage degeneration using optical coherence tomographyJOURNAL OF BIOMEDICAL OPTICSIF2.92007-01-0182OAAI
Controlled release of bioactive TGF-β1 from microspheres embedded within biodegradable hydrogelsBIOMATERIALSIF12.92006-03-01177PREAI
Interaction of azimilide with neurohumoral and channel receptorsBIOCHEMICAL PHARMACOLOGYIF5.62001-10-016PREAI
HL-1 cells: A cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocytePROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICAIF9.11998-03-171.5KOAAI
Regulation of calcium channel expression in neonatal myocytes by catecholamines儿茶酚胺对新生心肌细胞钙通道表达的调节JOURNAL OF CLINICAL INVESTIGATIONIF13.61996-02-0187OA